Noteworthy was also the observation from the 3-institution cohort that genetic aberrations of specific melanoma-associated genes were less frequent in APC/CTNNB1-mutant stage IV melanomas than the incidence of these mutations without (e.g., NF1, RAC1, and PTEN). The gene discussed is CTNNB1; the disease is melanoma.